tiprankstipranks
Teleflex Inc (TFX)
NYSE:TFX
US Market

Teleflex (TFX) Earnings Dates, Call Summary & Reports

Compare
407 Followers

Earnings Data

Report Date
May 01, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
2.99
Last Year’s EPS
3.21
Same Quarter Last Year
Based on 8 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 27, 2025
|
% Change Since: -25.27%
|
Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted growth in several segments and strategic initiatives, including a significant acquisition and a plan to separate into two companies. However, challenges in the Urology and OEM segments and a substantial goodwill impairment charge indicate significant hurdles ahead.
Company Guidance
In the Teleflex Fourth Quarter 2024 Earnings Conference Call, the company provided guidance for 2025, projecting adjusted constant currency growth of 1% to 2%, excluding a $13.8 million negative impact from an Italian measure incurred in the second quarter of 2024. They anticipate a $55 million, or 180 basis point, revenue headwind from foreign exchange translation, with a euro to dollar exchange rate assumption of 1.03. The guidance reflects continued pressure on the Interventional Urology business, particularly due to softness in UroLift, and challenges in the OEM business, which is facing temporary delays in customer orders and a prior contract loss. Volume-based procurement is expected to impact the Surgical business in China. The 2025 adjusted earnings per share are projected to be between $13.95 and $14.35, with adjusted gross margins ranging from 60.25% to 61% and adjusted operating margins from 26.6% to 27%. The net interest expense is estimated at $75 million, considering the impact from an accelerated share repurchase plan, and the adjusted tax rate is expected to be around 13.5%, with approximately 45.5 million average weighted shares inclusive of the share repurchase.
Revenue and Earnings Growth
Teleflex revenues for Q4 2024 were $795.4 million, up 2.8% year-over-year on a GAAP basis and 3.2% on an adjusted constant currency basis. Adjusted earnings per share grew 15.1% to $3.89.
Strong Performance in Interventional and Surgical Segments
The Interventional and Surgical businesses showed significant growth in the fourth quarter with adjusted constant currency growth of 18.7% and 12.3%, respectively.
Successful Cash Flow Management
Cash flow from operations increased 24.7% year-over-year to $638.3 million in 2024, compared to $511.7 million in the prior year period.
Strategic Acquisition Announcement
Teleflex announced the acquisition of BIOTRONIK's Vascular Intervention business for approximately EUR 760 million, expected to close by the end of Q3 2025.
Share Repurchase Program
A $300 million accelerated share repurchase program was announced, expected to complete the existing $500 million share repurchase program authorized in July 2024.
Separation into Two Independent Companies
Teleflex plans to separate into two independent publicly traded companies by mid-2026, with one focused on Vascular Access, Interventional, and Surgical, and the other on Urology, Acute Care, and OEM.
---

Teleflex (TFX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TFX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 01, 20252025 (Q1)
2.99 / -
3.21
Feb 27, 20252024 (Q4)
3.86 / 3.89
3.3815.09% (+0.51)
Oct 31, 20242024 (Q3)
3.39 / 3.49
3.64-4.12% (-0.15)
Aug 01, 20242024 (Q2)
3.33 / 3.42
3.410.29% (<+0.01)
May 02, 20242024 (Q1)
3.08 / 3.21
3.093.88% (+0.12)
Feb 22, 20242023 (Q4)
3.26 / 3.38
3.52-3.98% (-0.14)
Nov 02, 20232023 (Q3)
3.27 / 3.64
3.2711.31% (+0.37)
Aug 03, 20232023 (Q2)
3.21 / 3.41
3.390.59% (+0.02)
May 04, 20232023 (Q1)
2.97 / 3.09
2.887.29% (+0.21)
Feb 23, 20232022 (Q4)
3.44 / 3.52
3.6-2.22% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TFX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 27, 2025$177.63$139.11-21.69%
Oct 31, 2024$234.80$200.70-14.52%
Aug 01, 2024$220.20$235.18+6.80%
May 02, 2024$210.51$197.76-6.06%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Teleflex Inc (TFX) report earnings?
Teleflex Inc (TFX) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
    What is Teleflex Inc (TFX) earnings time?
    Teleflex Inc (TFX) earnings time is at May 01, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TFX EPS forecast?
          TFX EPS forecast for the fiscal quarter 2025 (Q1) is 2.99.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis